Publications by authors named "Robert Chitren"

Claim this Profile
N
Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple Myeloma.
Robert Chitren, Krishne Gowda, Shantu Amin, Gavin P Robertson, Subash Jonnalagadda

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells.
Weam Othman Elbezanti, Omar S Al-Odat, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
Omar Al-Odat, Max von Suskil, Robert Chitren, Weam Elbezanti, Sandeep Srivastava

Front Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Max Von Suskil, Kazi Nasrin Sultana, Weam Othman Elbezanti, Omar S Al-Odat, Robert Chitren

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Old drugs, new uses: Drug repurposing in hematological malignancies.
Vijay P Kale, Hasan Habib, Robert Chitren, Milan Patel, Kartick C Pramanik

Semin Cancer Biol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents.
Lucas N Solano, Grady L Nelson, Conor T Ronayne, Shirisha Jonnalagadda, Sravan K Jonnalagadda, Robert Chitren

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Saketh S Dinavahi, Raghavendra Gowda, Christopher G Bazewicz, Madhu Babu Battu, Jyh Ming Lin, Robert J Chitren

Eur J Med Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis